Status:
UNKNOWN
Lacosamide in Neonatal Status Epilepticus
Lead Sponsor:
Sherief Abd-Elsalam
Conditions:
Epilepsy
Eligibility:
All Genders
Up to 28 years
Phase:
PHASE3
Brief Summary
Lacosamide in neonatal status epilepticus
Detailed Description
The study will assess the efficacy of Lacosamide in neonatal status epilepticus
Eligibility Criteria
Inclusion
- neonates with status epilepticus
Exclusion
- congenital anomalies or organ dysfunction
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05291455
Start Date
March 1 2022
End Date
April 1 2024
Last Update
March 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kafrelsheikh University
Tanta, Kafrelsheikh, Egypt